Skip to main content
Landing Pages / Profile
Photo of Priyanka Vashisht, MD

Priyanka Vashisht, MD

Adjunct Associate Professor

Internal Medicine | College of Medicine

  • Fellowship: University of Nebraska (Rheumatology)
  • Residency: Creighton University (Internal Medicine )
  • Residency: LNR Foundation School (General Practice )
  • Residency: Delhi University (Dermatology )
  • Bachelor's Degree: Maulana Azad Medical College (Medicine and Surgery)
Board Certifications & Licenses

American Board of Internal Medicine (Rheumatology) (Certification Date: 2016-10-13)
American Board of Internal Medicine (Certification Date: 2012-08-15) - (Recertification Date: 2024-02-10)


Internal Medicine

Contact Information

Clinical Interests

Internal Medicine

Ankylosing Spondylitis

Autoimmune Vasculitis

Behcet Syndrome (Neuro-Bechet)

Central Nervous System Lupus Vasculitis

Collagen Disease

CREST Syndrome


Cutaneous, Leukocytoclastic, Vasculitis


Hip Rheumatoid Arthritis

Lupus (Systemic lupus erythematosus)

Lupus Erythematosus Panniculitis

Lupus Nephritis

Microscopic Polyangiitis

Mixed Connective Tissue Disease (MCTD)

Osteochondritis Dissecans

Overlap Connective Tissue Disease

Paget Disease

Polymyalgia Rheumatica




Psoriatic Arthritis

Raynaud Phenomenon in Scleroderma

Raynaud's Disease

Reactive Arthritis (Reiter's Syndrome)

Rheumatoid Arthritis

Rheumatoid Vasculitis

Still's Disease

Systemic Lupus Erythematosus (SLE)

Systemic Vasculitis

Takayasu Arteritis

Temporal Arteritis (Giant cell arteritis)

Vasculitis (Angiitis)

Weill-Marchesani Syndrome

Peer Reviewed Publications

Onuorah, Nneoma; Abraham, Hrudya; Vashisht, Priyanka 2020. The Diagnostic Conundrum of Felty Syndrome and T-Cell Large Granular Lymphocytic Leukemia. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, ,

Vashisht, Priyanka; O'dell, James 2017. Not all TNF inhibitors in rheumatoid arthritis are created equal: important clinical differences. Expert opinion on biological therapy, 17 8, 989-999

Vashisht P.;Sayles H.;Cannella A.;Mikuls T.;Michaud K. 10-01-2016. Generalizability of Patients With Rheumatoid Arthritis in Biologic Agent Clinical Trials Arthritis Care and Research, 68 10, 1478-1488

Wampler Muskardin T.;Vashisht P.;Dorschner J.M.;Jensen M.A.;Chrabot B.S.;Kern M.;Curtis J.R.;Danila M.I.;Cofield S.S.;Shadick N.;Nigrovic P.A.;St Clair E.W.;Bingham C.O.;Furie R.;Robinson W.;Genovese M.;Striebich C.C.;O'Dell J.R.;Thiele G.M.;Moreland L.W.;Levesque M.;Bridges S.L.;Gregersen P.K.;Niewold T.B. 10-01-2016. Increased pretreatment serum IFN-?/? ratio predicts non-response to tumour necrosis factor ? inhibit Annals of the rheumatic diseases, 75 10, 1757-1762

Vashisht P.;Borghoff K.;O'Dell J.;Hearth-Holmes M. 07-01-2017. Belimumab for the treatment of recalcitrant cutaneous lupus Lupus, 26 8, 857-864

Vashisht P.;Casale T. 01-01-2013. Omalizumab for treatment of allergic rhinitis Expert Opinion on Biological Therapy, 13 6, 933-945